For women diagnosed with breast cancer who wish to have children in the future, preserving fertility becomes a critical concern. It’s important to explore fertility preservation options before beginning cancer treatment, as certain therapies can affect reproductive health.
Breast cancer, which is one of the most common cancers in women, has traditionally been associated with older, postmenopausal women. However, due to shifts in lifestyle and health habits, an increasing number of younger women, including those of childbearing age, are at risk. For women diagnosed at a younger age, balancing cancer treatment with the possibility of future motherhood requires careful planning.
Dr. Rucha Kaushik, a breast cancer surgeon at P.D. Hinduja Hospital, explains how different cancer treatments affect fertility. Surgery alone, such as a lumpectomy or mastectomy, does not impact fertility directly. However, chemotherapy poses the greatest risk, as it can damage ovarian function, reduce egg reserves, or cause premature menopause. The likelihood of fertility recovery depends on the woman’s age, with women in their 30s having better chances of regaining menstrual function than those in their 40s. Radiotherapy and hormone therapy, while essential for treating certain cancers, can further complicate fertility, especially since hormone therapy may last several years.
Fortunately, women have options for preserving fertility. Specialized clinics offer services like egg and embryo freezing, as well as ovarian tissue freezing. These procedures allow women to potentially have children after completing their cancer treatments. Important factors to consider include age at diagnosis, the aggressiveness of the cancer, the timeline for fertility preservation procedures, financial costs, and emotional support. Although fertility preservation can be time-consuming and costly, it offers a vital path for women who wish to preserve their ability to have children in the future.
